Investment Banking for Healthcare & Life Sciences
[ 01/04 ] · WHY NOW
Growing Health Insurance Coverage
Ayushman Bharat expansion and state-backed schemes are driving higher insured patient volumes
Strengthening Domestic Medtech Manufacturing
Medical Devices PLI and import substitution initiatives are boosting local capability and competitiveness
Digital Health Infrastructure Scale-Up
ABDM rails enable e-claims, interoperability and digital care pathways across the health ecosystem
Increasing Pharma & CDMO Momentum
Global supply-chain rebalancing and specialty therapeutics are supporting steady demand growth
[ 02/04 ] · OUR FOCUS
What We Focus On
A detailed look at the operational, compliance and analytics levers we evaluate to strengthen your IPO readiness
Regulation and compliance CDSCO or MDR classes and licenses, GMP, DCGI, NDCTR registry, NLEM or DPCO exposure
Unit economics ARPOB, ALOS, occupancy, doctor productivity, payor mix; diagnostics realisations per test and throughput; device ASPs and channel margins; pharma price erosion, ANDA launches and DMFs
Quality and risk NABH or NABL accreditations, pharmacovigilance, recall or CAPA history, data privacy and ABDM integration
Growth engines brownfield and greenfield pipeline, network expansion, PLI capacity adds, brand or IP portfolio and export registrations
[ 03/04 ] · DELIVERABLES
Our Deliverables
A comprehensive, end-to-end IPO execution stack delivered with precision and consistency

Readiness Score & Fix List
Across licenses, consents and disclosures in 48 hours

DRHP Chapter Set
And data-room index with evidence trails

Indicative Pricing Bands
Vs India and global comps across providers, diagnostics, medtech, pharma and CDMO

Anchor Map
Book-build plan by investor archetype

IR Toolkit
KPI pack by sub-sector providers ARPOB or ALOS or occupancy; diagnostics realisations per test; pharma or CDMO ANDA pipeline and launches plus analyst deck and earnings model
*Timelines are indicative and depend on issuer readiness, audit completion, legal diligence, SEBI observations and market conditions. We do not guarantee pricing or allotment
[ 04/04 ] · FAQs
Answers to Common Questions
Learn about S45's IPO services, process, and what to expect
CTA